Spok, Inc., a wholly owned subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK) and the global leader in healthcare communications, announced that all 20 hospitals named to U.S. News & World Report’s 2017-18 Best Hospitals Honor Roll and all 10 hospitals named to the 2017-18 Best Children’s Hospitals Honor Roll rely on Spok® solutions for enterprise healthcare communications. This is the fifth consecutive year that all of the Honor Roll hospitals are Spok customers.

Insurance giant Anthem continued its departure from Affordable Care Act (ACA) exchanges, announcing it will no longer offer plans in Nevada and 74 counties in Georgia.

Playing video game can reduce the amount of gray matter in the hippocampus region of the brain by using spatial learning, navigation and memory. In a study published in Molecular Psychiatry, researchers evaluated which types of games affect the brain.

Milestone Scientific Inc. (NYSE: MLSS) a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that the first patient in the U.S was treated with the CompuFlo® Epidural Instrument at the University of Miami Hospital, following Milestone Scientific’s receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) on June 9, 2017. The CompuFlo® Epidural Instrument provides anesthesiologists and medical practitioners, for the first time, with the unique ability to objectively identify and confirm the epidural space.

Medical researchers are utilizing electronic health records (EHRs) to conduct research on a variety of conditions. A recent study in Circulation evaluated the accuracy of EHR data provided for cardiovascular care traditionally obtained data.

Described in the recent issue of Nature Nanotechnology, a technology called Tissue Nanotransfection (TNT) technology has shown an ability to transform skin cells into other types of cells with 98 percent accuracy, with the potential ability to save failing organs.

IBM's artificial intelligence platform Watson is being trained to help cancer patients receive more personalized care by identifying the specific genetic mutations causing their disease. With Watson's reports, healthcare providers will be able to develop and administer therapies to directly treat each patient.

CMS has approved a five-year extension of Florida’s statewide Medicaid managed care demonstration, including $1.5 billion in funding for support uncompensated care for low-income patients.